Wednesday’s earnings report from MercadoLibre lands in circumstances that have changed dramatically since the company last filed. MercadoLibre is expected to report Q3 2026 results after the market closes on November 4, though the company has not formally confirmed the date. Analysts expect earnings of $9.28 per share on revenue of $10.69 billion. Those are clean numbers on paper. The context surrounding them is anything but.
Why This Stock Now
The question going into tomorrow is not whether MELI can grow. It is whether the business underneath the growth is getting stronger or quietly more fragile. Lula’s runoff victory triggered a sharp selloff in Brazilian assets, with the Ibovespa down roughly 14% and the real down about 8% on October 26. That is the macro backdrop MELI is reporting into. The expectation of expansionist fiscal policy in Lula’s new administration increases fiscal risk perception for Brazilian assets, keeping the real under pressure. Brazil is MELI’s largest market. The real is inside every revenue line and every loan balance the company reports.
The Business
MercadoLibre operates Latin America’s dominant e-commerce and fintech ecosystem. Q2 2026 net revenue and financial income totaled $10.169 billion, up 50% year over year, with Brazil continuing to show the strongest trends. The growth is genuine and the scale is real. The problem is what sits alongside it.
The market is not debating whether MELI can grow; it is debating whether that growth is worth the margin being burned to get there. Q2 marked MELI’s third consecutive quarter of declining net profit, with net income down 11% year over year to $466 million. Operating margin fell 550 basis points year over year to 6.7% in Q2. The company is spending aggressively and saying the returns come later. Investors who bought that argument earlier in 2026 have watched the stock trade from a 52-week high near $2,420 down to around $1,677 today.
What Wall Street Is Watching
The credit book is the sharpest debate heading into Wednesday. MELI’s credit portfolio reached $16.4 billion in Q2, growing 75% year over year, with 15-90 day NPLs near historical lows at 7.0% for the total portfolio and 4.6% for credit cards. Management in August was firm: Fintech President Osvaldo Giménez said there were no important signs of deterioration in Brazil, with NPLs roughly in line with a year ago and better than the prior quarter.
That assessment predates the election. The real’s slide and the fiscal uncertainty now surrounding Lula’s fourth term are exactly the conditions that stress consumer credit books. The book has never been tested at this scale in a downturn, and a 200 basis point NPL increase would likely mean a meaningful step-up in provisioning. What the Q3 numbers show on NPLs and provision charges will matter more than the revenue figure.
There is a bull case. The credit card portfolio grew 104% year over year to $6.6 billion in Q1 2026, with management saying card cohorts typically reach breakeven after 12 to 18 months. Most of the portfolio was issued in the last two years, making the losses a timing issue rather than a structural one. Net interest margin after losses improved from 18% in Q1 2026 to 20.7% in Q2.
What Could Go Wrong
Currency translation is the immediate risk. A weaker real means Brazil revenue and loan balances shrink in dollar terms even if local volumes hold. Investors remain focused on fiscal policy and the government’s commitment to controlling spending, with concerns intensifying amid uncertainty over key appointments and fiscal direction. If the real stays near R$5.40 or weakens further, Q3 guidance commentary will carry more weight than the reported figures.
UBS holds a Neutral rating with a $1,750 target, a posture that reflects the unresolved tension between strong top-line momentum and persistent margin pressure. The EPS miss risk is real: analysts had Q2 consensus at $8.65 and the company delivered $9.19, but Q1 was a miss that rattled the stock. With consensus now at $9.28, there is limited room for another stumble.
The Bottom Line
MELI trading at roughly $1,677, against a 52-week high near $2,420, looks like a discount on one of the most powerful compounders in emerging markets. The current P/E is about 46x, down from where it has often traded in prior years. That compression exists for a reason: three quarters of declining profit, a credit book scaling into an untested macro environment, and now a Brazil that just repriced its political risk overnight.
The honest answer to whether MELI is a growth stock on sale or one to leave alone is that Wednesday’s numbers decide it. If Q3 shows credit quality holding, provisions stabilizing, and management offering any floor on margin compression, the discount is compelling. If NPLs tick up meaningfully into a post-election Brazil and the real continues to erode the revenue line, patience is the only rational response. Watch the credit charges first. Revenue will take care of itself.
